High-fat diet decreases energy expenditure and expression of genes controlling lipid metabolism, mitochondrial function and skeletal system development in the adipose tissue, along with increased expression of extracellular matrix remodelling- and inflammation-related genes

British Journal of Nutrition

Volumn 113, Issue 6, 2015, Pages 867-877

  Choi, Myung Sook ^a   Kim, Young Je ^a   Kwon, Eun Young ^a   Ryoo, Jae Young ^a   Kim, Sang Ryong ^a   Jung, Un Ju ^a  

^a Kyungpook National University   (South Korea)

Author keywords

Energy expenditure; Global gene expression in adipose tissue; High fat diet; Inflammation

Indexed keywords

COLLAGEN; CYTOCHROME P450 2E1; CYTOKINE; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; RESISTIN; BIOLOGICAL MARKER; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LONG CHAIN FATTY ACID COENZYME A LIGASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

ACSM3 GENE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; C57BL 6 MOUSE; CALORIC INTAKE; CONTROLLED STUDY; CYP2E1 NAME; DIET INDUCED OBESITY; DOWN REGULATION; DYSLIPIDEMIA; ENERGY EXPENDITURE; EXTRACELLULAR MATRIX; FAM13A GENE; FATTY ACID METABOLISM; FOOD INTAKE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; GPNMB GENE; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPID METABOLISM; LIPOLYSIS; LOW FAT DIET; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL ENERGY TRANSFER; MITOCHONDRION; MOUSE; MOUSE MODEL; MT ND6 GENE; NONHUMAN; OBESITY; OXIDATION REDUCTION REACTION; RGS1 GENE; UPREGULATION; ADVERSE EFFECTS; ANIMAL; BLOOD; C57BL MOUSE; ENERGY METABOLISM; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKELETAL MUSCLE; WHITE ADIPOSE TISSUE;

MUS;

ADIPOSE TISSUE, WHITE; ADIPOSITY; ANIMALS; BIOLOGICAL MARKERS; COENZYME A LIGASES; CYTOCHROME P-450 CYP2E1; DIET, HIGH-FAT; ENERGY METABOLISM; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GTPASE-ACTIVATING PROTEINS; INSULIN RESISTANCE; MALE; MICE, INBRED C57BL; MITOCHONDRIA; MUSCLE, SKELETAL; NADH DEHYDROGENASE; OBESITY;

EID: 84926996744     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114515000100     Document Type: Article

References (67)

1. Jung UJ & Choi MS (2014) Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 15, 6184-6223.
2. Rolls BJ & Hammer VA (1995) Fat, carbohydrate, and the regulation of energy intake. Am J Clin Nutr 62, 1086S-1095S.
3. Savastano DM & Covasa M (2005) Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr 135, 1953-1959.
4. Buettner R, Newgard CB, Rhodes CJ, et al. (2000) Correction of diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance by moderate hyperleptinemia. Am J Physiol Endocrinol Metab 278, E563-E569.
5. Leibowitz SF, Dourmashkin JT, Chang GQ, et al. (2004) Acute high-fat diet paradigms link galanin to triglycerides and their transport and metabolism in muscle. Brain Res 1008, 168-178.
6. Do GM, Oh HY, Kwon EY, et al. (2011) Long-term adaptation of global transcription and metabolism in the liver of high-fat diet-fed C57BL/6J mice. Mol Nutr Food Res 55, S173-S185.
7. Kalupahana NS, Voy BH, Saxton AM, et al. (2011) Energyrestricted high-fat diets only partially improve markers of systemic and adipose tissue inflammation. Obesity (Silver Spring) 19, 245-254.
8. Oscai LB, Miller WC & Arnall DA (1987) Effects of dietary sugar and of dietary fat on food intake and body fat content in rats. Growth 51, 64-73.
9. Hulman S & Falkner B (1994) The effect of excess dietary sucrose on growth, blood pressure, and metabolism in developing Sprague-Dawley rats. Pediatr Res 36, 95-101.
10. Santos FL, Esteves SS, da Costa Pereira A, et al. (2012) Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev 13, 1048-1066.
11. Ruth MR, Port AM, Shah M, et al. (2013) Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism 62, 1779-1787.
12. Hageman RS, Wagener A, Hantschel C, et al. (2010) High-fat diet leads to tissue-specific changes reflecting risk factors for diseases in DBA/2J mice. Physiol Genomics 42, 55-66.
13. Bjørndal B, Burri L, Staalesen V, et al. (2011) Different adipose depots: their role in the development of metabolic syndrome and mitochondrial response to hypolipidemic agents. J Obes 2011, 490650.
14. Chau YY, Bandiera R, Serrels A, et al. (2014) Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source. Nat Cell Biol 16, 367-375.
15. Briones AM, Nguyen Dinh Cat A, Callera GE, et al. (2012) Adipocytes produce aldosterone through calcineurindependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction. Hypertension 59, 1069-1078.
16. Xu H, Barnes GT, Yang Q, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesityrelated insulin resistance. J Clin Invest 112, 1821-1830.
17. Altintas MM, Azad A, Nayer B, et al. (2011) Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J Lipid Res 52, 480-488.
18. Liu LF, Shen WJ, Ueno M, et al. (2013) Age-related modulation of the effects of obesity on gene expression profiles of mouse bone marrow and epididymal adipocytes. PLOS ONE 8, e72367.
19. Do GM, Kwon EY, Kim E, et al. (2010) Hepatic transcription response to high-fat treatment in mice: microarray comparison of individual vs. pooled RNA samples. Biotechnol J 5, 970-973.
20. Lin S, Thomas TC, Storlien LH, et al. (2000) Development of high fat diet-induced obesity and leptin resistance in C57Bl/ 6J mice. Int J Obes Relat Metab Disord 24, 639-646.
21. Flachs P, Rossmeisl M, Kuda O, et al. (2013) Stimulation of mitochondrial oxidative capacity in white fat independent of UCP1: a key to lean phenotype. Biochim Biophys Acta 1831, 986-1003.
22. Valerio A, Cardile A, Cozzi V, et al. (2006) TNF-alpha downregulates eNOS expression and mitochondrial biogenesis in fat and muscle of obese rodents. J Clin Invest 116, 2791-2798.
23. Böttcher H & Fürst P (1997) Decreased white fat cell thermogenesis in obese individuals. Int J Obes Relat Metab Disord 21, 439-444.
24. Kusminski CM & Scherer PE (2012) Mitochondrial dysfunction in white adipose tissue. Trends Endocrinol Metab 23, 435-443.
25. Blüher M, Engeli S, Klöting N, et al. (2006) Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55, 3053-3060.
26. Vaitheesvaran B, Yang L, Hartil K, et al. (2012) Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregulated lysine acetylation. PLOS ONE 7, e33717.
27. Muoio DM & Neufer PD (2012) Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab 15, 595-605.
28. Tormos KV, Anso E, Hamanaka RB, et al. (2011) Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab 14, 537-544.
29. Furukawa S, Fujita T, Shimabukuro M, et al. (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114, 1752-1761.
30. Qian SW, Tang Y, Li X, et al. (2013) BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis. Proc Natl Acad Sci U S A 110, E798-E807.
31. Yamamoto Y, Gesta S, Lee KY, et al. (2010) Adipose depots possess unique developmental gene signatures. Obesity (Silver Spring) 18, 872-878.
32. Dankel SN, Fadnes DJ, Stavrum AK, et al. (2010) Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS ONE 5, e11033.
33. Gehrke S, Brueckner B, Schepky A, et al. (2013) Epigenetic regulation of depot-specific gene expression in adipose tissue. PLOS ONE 8, e82516.
34. Chen M, Macpherson A, Owens J, et al. (2012) Obesity alone or with type 2 diabetes is associated with tissue specific alterations in DNA methylation and gene expression of PPARGC1A and IGF2. J Diabetes Res Clin Metab 1, 1-8.
35. Morita S, Horii T, Kimura M, et al. (2014) Paternal allele influences high fat diet-induced obesity. PLOS ONE 9, e85477.
36. Revelli JP, Preitner F, Samec S, et al. (1997) Targeted gene disruption reveals a leptin-independent role for the mouse beta3-adrenoceptor in the regulation of body composition. J Clin Invest 100, 1098-1106.
37. Arner P & Hoffstedt J (1999) Adrenoceptor genes in human obesity. J Intern Med 245, 667-672.
38. Scheja L, Makowski L, Uysal KT, et al. (1999) Altered insulin secretion associated with reduced lipolytic efficiency in aP22/2 mice. Diabetes 48, 1987-1994.
39. Queipo-Ortuño MI, Escoté X, Ceperuelo-Mallafré V, et al. (2012) FABP4 dynamics in obesity: discrepancies in adipose tissue and liver expression regarding circulating plasma levels. PLOS ONE 7, e48605.
40. Ichimura A, Hirasawa A, Poulain-Godefroy O, et al. (2012) Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human. Nature 483, 350-354.
41. Wanders D, Graff EC & Judd RL (2012) Effects of high fat diet on GPR109A and GPR81 gene expression. Biochem Biophys Res Commun 425, 278-283.
42. De Vries L, Zheng B, Fischer T, et al. (2000) The regulator of G protein signaling family. Annu Rev Pharmacol Toxicol 40, 235-271.
43. Huang X, Charbeneau RA, Fu Y, et al. (2008) Resistance to diet-induced obesity and improved insulin sensitivity in mice with a regulator of G protein signaling-insensitive G184S Gnai2 allele. Diabetes 57, 77-85.
44. Cho H, Park C, Hwang IY, et al. (2008) Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol 28, 2590-2597.
45. Nunn C, Zhao P, Zou MX, et al. (2011) Resistance to agerelated, normal body weight gain in RGS2 deficient mice. Cell Signal 23, 1375-1386.
46. Crandall DL, Hausman GJ & Kral JG (1997) A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 4, 211-232.
47. Järveläinen H, Sainio A, Koulu M, et al. (2009) Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev 61, 198-223.
48. Lijnen HR, Demeulemeester D, Van Hoef B, et al. (2003) Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice. Thromb Haemost 89, 249-255.
49. Masaki M, Kurisaki T, Shirakawa K, et al. (2005) Role of meltrin {alpha} (ADAM12) in obesity induced by high-fat diet. Endocrinology 146, 1752-1763.
50. Van Hul M & Lijnen HR (2008) A functional role of gelatinase A in the development of nutritionally induced obesity in mice. J Thromb Haemost 6, 1198-1206.
51. Yang M, Zhang Y, Pan J, et al. (2007) Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 9, 970-977.
52. Yang M, Sun J, Zhang T, et al. (2008) Deficiency and inhibition of cathepsin K reduce body weight gain and increase glucose metabolism in mice. Arterioscler Thromb Vasc Biol 28, 2202-2208.
53. Van Hul M, Piccard H & Lijnen HR (2010) Gelatinase B (MMP-9) deficiency does not affect murine adipose tissue development. Thromb Haemost 104, 165-171.
54. Belo VA, Souza-Costa DC, Luizon MR, et al. (2012) Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children. Int J Obes (Lond) 36, 69-75.
55. Kanda H, Tateya S, Tamori Y, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116, 1494-1505.
56. Kamei N, Tobe K, Suzuki R, et al. (2006) Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 281, 26602-26614.
57. Nara N, Nakayama Y, Okamoto S, et al. (2007) Disruption of CXC motif chemokine ligand-14 in mice ameliorates obesityinduced insulin resistance. J Biol Chem 282, 30794-30803.
58. Kitade H, Sawamoto K, Nagashimada M, et al. (2012) CCR5 plays a critical role in obesity-induced adipose tissue inflammation and insulin resistance by regulating both macrophage recruitment and M1/M2 status. Diabetes 61, 1680-1690.
59. Kintscher U, Hartge M, Hess K, et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28, 1304-1310.
60. Winer DA, Winer S, Shen L, et al. (2011) B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat Med 17, 610-617.
61. Himes RW & Smith CW (2010) Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J 24, 731-739.
62. Yang RZ, Lee MJ, Hu H, et al. (2006) Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 3, 884-894.
63. Thomas AP, Dunn TN, Oort PJ, et al. (2011) Inflammatory phenotyping identifies CD11d as a gene markedly induced in white adipose tissue in obese rodents and women. J Nutr 141, 1172-1180.
64. Yadav VK, Oury F, Suda N, et al. (2009) A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 138, 976-989.
65. Canaan A, Defuria J, Perelman E, et al. (2014) Extended lifespan and reduced adiposity in mice lacking the FAT10 gene. Proc Natl Acad Sci U S A 111, 5313-5318.
66. Suganami T, Yuan X, Shimoda Y, et al. (2009) Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ Res 105, 25-32.
67. Jang MK, Son Y & Jung MH (2013) ATF3 plays a role in adipocyte hypoxia-mediated mitochondria dysfunction in obesity. Biochem Biophys Res Commun 431, 421-427.